V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20202207 | 20167141 | 1.76 | 54 | Neo-adjuvant (N) | 2021-09-03 | 2021-10-29 | Docetaxel | 02 | N | DOCETAXEL | 101741088 |
| 20202228 | 20167142 | 1.7 | 96 | Palliative (P) | 2018-11-11 | 2018-11-13 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101647693 |
| 20202257 | 20167143 | 1.75 | 72 | null | 2016-05-17 | 2016-10-13 | CETUXIMAB + IRINOTECAN + MDG | N | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101809116 |
| 20202258 | 20167144 | 1.91 | 64.5 | Palliative (P) | 2022-03-11 | 2022-04-23 | Docetaxel | 02 | N | DOCETAXEL | 100789068 |
| 20202260 | 20167145 | 1.88 | 80.6 | Palliative (P) | 2016-10-09 | 2016-10-20 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101538692 |
| 20202274 | 20167146 | 1.93 | 73.9 | null | 2018-07-26 | 2018-10-25 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101826017 |
| 20202302 | 20167147 | 1.74 | 66.3 | null | 2020-01-28 | 2020-02-11 | Cetuximab + FOLFIRI cycle1 | 02 | null | DOCETAXEL | 100278007 |
| 20202305 | 20167148 | 1.74 | 83.9 | Palliative (P) | 2017-04-16 | 2017-04-16 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101276186 |
| 20202309 | 20167149 | 1.41 | 55.9 | Palliative (P) | 2016-05-19 | 2016-05-23 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100959483 |
| 20202310 | 20167150 | 1.66 | 87.5 | null | 2019-01-20 | 2019-01-27 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CAPECITABINE + GEMCITABINE | 100195075 |
| 20202334 | 20167151 | 1.47 | 79 | Palliative (P) | 2018-01-20 | 2018-03-04 | Cetuximab + FOLFIRI cycle1 | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101090338 |
| 20202341 | 20167152 | 1.7 | 68 | Palliative (P) | 2021-04-06 | 2021-05-30 | Docetaxel | 02 | N | DOCETAXEL | 100460292 |
| 20202344 | 20167153 | 1.5 | 75.8 | Palliative (P) | 2017-12-02 | 2017-12-02 | Docetaxel | 02 | N | DOCETAXEL | 101047814 |
| 20202360 | 20167154 | 0 | 60.2 | Neo-adjuvant (N) | 2017-09-26 | 2017-12-26 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | DOCETAXEL | 100981173 |
| 20202363 | 20167155 | 1.7 | 59 | null | 2019-05-20 | 2019-05-26 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 101776427 |
| 20202375 | 20167156 | 1.79 | 73 | Palliative (P) | 2020-12-13 | 2020-12-29 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101535446 |
| 20202376 | 20167157 | 1.76 | 99 | Palliative (P) | 2018-05-05 | 2018-05-24 | Cetuximab + FOLFIRI cycle 2 onwards | 2 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101092564 |
| 20202393 | 20167158 | 1.8 | 70 | Palliative (P) | 2019-01-04 | 2019-02-09 | Docetaxel 75mg/m2 (21 day) | N | N | DOCETAXEL | 100697696 |
| 20202403 | 20167159 | 1.76 | 95.8 | Palliative (P) | 2019-12-15 | 2020-12-20 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101833025 |
| 20202413 | 20167160 | 1.5 | 92.4 | Palliative (P) | 2019-03-13 | 2019-12-27 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | DOCETAXEL | 100503344 |
| 20202426 | 20167161 | 1.5 | 52.2 | null | 2019-09-04 | 2019-09-10 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 100984833 |
| 20202444 | 20167162 | 1.36 | 60.3 | null | 2021-01-30 | 2021-02-07 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 100048712 |
| 20202450 | 20167163 | 1.7 | 76.2 | Palliative (P) | 2020-01-07 | 2020-01-17 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100011491 |
| 20202472 | 20167164 | 1.66 | 70 | null | 2019-12-08 | 2019-12-22 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | DOCETAXEL | 100788200 |
| 20202486 | 20167165 | 1.66 | 72 | Palliative (P) | 2020-02-08 | 2020-03-04 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101029462 |
| 20202490 | 20167166 | 1.69 | 86.2 | Palliative (P) | 2019-08-11 | 2019-09-22 | Docetaxel | 02 | N | DOCETAXEL | 100356545 |
| 20202505 | 20167167 | 1.78 | 61.1 | null | null | 2019-03-20 | Cetuximab + FOLFIRI cycle1 | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100071955 |
| 20202508 | 20167168 | 1.86 | 62.3 | Palliative (P) | 2018-04-04 | 2018-04-24 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 100052360 |
| 20202509 | 20167169 | 1.93 | 45.7 | null | 2017-10-10 | 2017-10-22 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101777614 |
| 20202517 | 20167170 | 1.76 | 74.4 | Palliative (P) | 2016-05-31 | 2016-09-26 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101031542 |
| 20202534 | 20167171 | 1.66 | 46.1 | Palliative (P) | 2018-06-25 | 2018-07-13 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CAPECITABINE + GEMCITABINE | 101469829 |
| 20202536 | 20167172 | 1.75 | 79.4 | Palliative (P) | 2020-12-28 | 2021-01-02 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100604367 |
| 20202551 | 20167173 | 1.69 | 65.4 | Curative (C) | 2018-06-16 | 2018-06-19 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100398638 |
| 20202556 | 20167174 | 1.87 | 78.15 | null | 2020-05-25 | 2020-06-01 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100366150 |
| 20202561 | 20167175 | 1.69 | 42.9 | Palliative (P) | 2022-02-05 | 2022-02-24 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100881442 |
| 20202577 | 20167176 | 1.95 | 71.6 | Neo-adjuvant (N) | 2021-02-06 | 2021-09-26 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101638970 |
| 20202587 | 20167177 | 1.61 | 102 | null | 2020-12-07 | 2021-01-09 | Cetuximab + FOLFIRI cycle1 | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100421896 |
| 20202599 | 20167178 | 1.87 | 86 | null | 2020-05-18 | 2020-05-20 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101650403 |
| 20202604 | 20167179 | 1.59 | 61.8 | Palliative (P) | 2020-02-04 | 2020-02-05 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CAPECITABINE + GEMCITABINE | 101338829 |
| 20202605 | 20167180 | 1.61 | 86.7 | Palliative (P) | 2017-12-28 | 2018-03-01 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100215306 |
| 20202613 | 20167181 | 1.8 | 70 | Palliative (P) | 2021-04-07 | 2021-07-08 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101215453 |
| 20202626 | 20167182 | 1.61 | 96 | 03 | 2017-12-30 | 2018-01-08 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101346855 |
| 20202633 | 20167183 | null | 86.5 | Palliative (P) | 2017-05-30 | 2017-05-30 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100988161 |
| 20202636 | 20167184 | 1.59 | 74.3 | null | 2019-12-05 | 2019-12-12 | Docetaxel | 02 | null | DOCETAXEL | 101405354 |
| 20202645 | 20167185 | 1.55 | 74 | Palliative (P) | 2019-02-03 | 2019-02-03 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101757259 |
| 20202647 | 20167186 | 1.61 | 54.2 | Palliative (P) | 2017-12-06 | 2017-12-20 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101410878 |
| 20202661 | 20167187 | 1.7 | 59.8 | Palliative (P) | 2018-11-09 | 2018-11-16 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CAPECITABINE + GEMCITABINE | 100950247 |
| 20202685 | 20167188 | 1.52 | 99.3 | Palliative (P) | 2022-02-27 | 2022-03-06 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101165156 |
| 20202701 | 20167189 | 1.74 | 57.6 | null | 2021-03-30 | 2021-04-12 | Docetaxel | 02 | null | DOCETAXEL | 101494517 |
| 20202704 | 20167190 | 1.7 | 61.5 | null | 2016-05-06 | 2016-07-06 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 100843821 |